Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 490

1.

A symptom combination predicting treatment-resistant schizophrenia - A strategy for real-world clinical practice.

Ortiz BB, Higuchi CH, Noto C, Joyce DW, Correll CU, Bressan RA, Gadelha A.

Schizophr Res. 2020 Jan 16. pii: S0920-9964(20)30017-7. doi: 10.1016/j.schres.2020.01.002. [Epub ahead of print]

PMID:
31956005
2.

20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20).

Taipale H, Tanskanen A, Mehtälä J, Vattulainen P, Correll CU, Tiihonen J.

World Psychiatry. 2020 Feb;19(1):61-68. doi: 10.1002/wps.20699.

3.

Metformin add-on vs. antipsychotic switch vs. continued antipsychotic treatment plus healthy lifestyle education in overweight or obese youth with severe mental illness: results from the IMPACT trial.

Correll CU, Sikich L, Reeves G, Johnson J, Keeton C, Spanos M, Kapoor S, Bussell K, Miller L, Chandrasekhar T, Sheridan EM, Pirmohamed S, Reinblatt SP, Alderman C, Scheer A, Borner I, Bethea TC, Edwards S, Hamer RM, Riddle MA.

World Psychiatry. 2020 Feb;19(1):69-80. doi: 10.1002/wps.20714.

4.

Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial.

Correll CU, Davis RE, Weingart M, Saillard J, O'Gorman C, Kane JM, Lieberman JA, Tamminga CA, Mates S, Vanover KE.

JAMA Psychiatry. 2020 Jan 8. doi: 10.1001/jamapsychiatry.2019.4379. [Epub ahead of print]

5.

The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research.

Potkin SG, Kane JM, Correll CU, Lindenmayer JP, Agid O, Marder SR, Olfson M, Howes OD.

NPJ Schizophr. 2020 Jan 7;6(1):1. doi: 10.1038/s41537-019-0090-z. Review.

6.

Exploration of Treatment-Resistant Schizophrenia Subtypes Based on a Survey of 204 US Psychiatrists.

Correll CU, Brevig T, Brain C.

Neuropsychiatr Dis Treat. 2019 Dec 19;15:3461-3473. doi: 10.2147/NDT.S234813. eCollection 2019.

7.

What is good mental health? A scoping review.

Fusar-Poli P, Salazar de Pablo G, De Micheli A, Nieman DH, Correll CU, Kessing LV, Pfennig A, Bechdolf A, Borgwardt S, Arango C, van Amelsvoort T.

Eur Neuropsychopharmacol. 2020 Feb;31:33-46. doi: 10.1016/j.euroneuro.2019.12.105. Epub 2019 Dec 31. Review.

8.

Metabolic Monitoring Rates of Youth Treated with Second-Generation Antipsychotics in Usual Care: Results of a Large US National Commercial Health Plan.

Hayden JD, Horter L, Parsons T , III, Ruble M, Townsend S, Klein CC, Duran RP, Welge JA, Crystal S, Patel NC, Correll CU, DelBello MP.

J Child Adolesc Psychopharmacol. 2019 Dec 17. doi: 10.1089/cap.2019.0087. [Epub ahead of print]

PMID:
31851522
9.

Disparities in cancer screening in people with mental illness across the world versus the general population: prevalence and comparative meta-analysis including 4 717 839 people.

Solmi M, Firth J, Miola A, Fornaro M, Frison E, Fusar-Poli P, Dragioti E, Shin JI, Carvalho AF, Stubbs B, Koyanagi A, Kisely S, Correll CU.

Lancet Psychiatry. 2020 Jan;7(1):52-63. doi: 10.1016/S2215-0366(19)30414-6. Epub 2019 Nov 29. Erratum in: Lancet Psychiatry. 2019 Dec 4;:.

PMID:
31787585
10.

Predictors of psychosis breakthrough during 24 months of long-acting antipsychotic maintenance treatment in first episode schizophrenia.

Emsley R, Asmal L, Rubio JM, Correll CU, Kane JM.

Schizophr Res. 2019 Nov 22. pii: S0920-9964(19)30532-8. doi: 10.1016/j.schres.2019.11.025. [Epub ahead of print]

PMID:
31767510
11.

Most recommended medical interventions reach P<0.005 for their primary outcomes in meta-analyses.

Koletsi D, Solmi M, Pandis N, Fleming PS, Correll CU, Ioannidis JPA.

Int J Epidemiol. 2019 Nov 25. pii: dyz241. doi: 10.1093/ije/dyz241. [Epub ahead of print]

PMID:
31764988
12.

Long-Acting Injections in Schizophrenia: a 3-Year Update on Randomized Controlled Trials Published January 2016-March 2019.

Peters L, Krogmann A, von Hardenberg L, Bödeker K, Nöhles VB, Correll CU.

Curr Psychiatry Rep. 2019 Nov 19;21(12):124. doi: 10.1007/s11920-019-1114-0. Review.

PMID:
31745659
13.

Rare copy number variants in individuals at clinical high risk for psychosis: Enrichment of synaptic/brain-related functional pathways.

Jagannath V, Grünblatt E, Theodoridou A, Oneda B, Roth A, Gerstenberg M, Franscini M, Traber-Walker N, Correll CU, Heekeren K, Rössler W, Rauch A, Walitza S.

Am J Med Genet B Neuropsychiatr Genet. 2020 Mar;183(2):140-151. doi: 10.1002/ajmg.b.32770. Epub 2019 Nov 19.

PMID:
31742845
14.

Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists.

Correll CU, Brevig T, Brain C.

BMC Psychiatry. 2019 Nov 14;19(1):362. doi: 10.1186/s12888-019-2318-x.

15.

Is Transcultural Psychiatry Possible?

Guinart D, Kane JM, Correll CU.

JAMA. 2019 Nov 14. doi: 10.1001/jama.2019.17331. [Epub ahead of print] No abstract available.

PMID:
31725822
16.

Ranking Antipsychotics for Efficacy and Safety in Schizophrenia.

Correll CU, Kane JM.

JAMA Psychiatry. 2019 Nov 6. doi: 10.1001/jamapsychiatry.2019.3377. [Epub ahead of print] No abstract available.

PMID:
31693073
17.

Clinical Characteristics of Inpatients with Childhood vs. Adolescent Anorexia Nervosa.

Jaite C, Bühren K, Dahmen B, Dempfle A, Becker K, Correll CU, Egberts KM, Ehrlich S, Fleischhaker C, von Gontard A, Hahn F, Kolar D, Kaess M, Legenbauer T, Renner TJ, Schulze U, Sinzig J, Thomae E, Weber L, Wessing I, Antony G, Hebebrand J, Föcker M, Herpertz-Dahlmann B.

Nutrients. 2019 Oct 28;11(11). pii: E2593. doi: 10.3390/nu11112593.

18.

Impact of age and CYP2D6 genetics on exposure of aripiprazole and dehydroaripiprazole in patients using long-acting injectable versus oral formulation: relevance of poor and intermediate metabolizer status.

Tveito M, Molden E, Høiseth G, Correll CU, Smith RL.

Eur J Clin Pharmacol. 2020 Jan;76(1):41-49. doi: 10.1007/s00228-019-02768-0. Epub 2019 Oct 21.

PMID:
31637453
19.

Lithium Exposure During Pregnancy and the Postpartum Period: A Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes.

Fornaro M, Maritan E, Ferranti R, Zaninotto L, Miola A, Anastasia A, Murru A, Solé E, Stubbs B, Carvalho AF, Serretti A, Vieta E, Fusar-Poli P, McGuire P, Young AH, Dazzan P, Vigod SN, Correll CU, Solmi M.

Am J Psychiatry. 2020 Jan 1;177(1):76-92. doi: 10.1176/appi.ajp.2019.19030228. Epub 2019 Oct 18.

PMID:
31623458
20.

Incontinence and constipation in adolescent patients with anorexia nervosa-Results of a multicenter study from a German web-based registry for children and adolescents with anorexia nervosa.

Mattheus HK, Wagner C, Becker K, Bühren K, Correll CU, Egberts KM, Ehrlich S, Fleischhaker C, Föcker M, Hahn F, Hebebrand J, Herpertz-Dahlmann B, Jaite C, Jenetzky E, Kaess M, Legenbauer PhD T, Pfeiffer PhD JP, Renner Md TJ, Roessner V, Schulze U, Sinzig J, Wessing I, von Gontard A.

Int J Eat Disord. 2020 Feb;53(2):219-228. doi: 10.1002/eat.23182. Epub 2019 Oct 16.

PMID:
31617610

Supplemental Content

Loading ...
Support Center